Phase I – Other

1,082 trials 243 recruiting

Filter these 1,082 trials by condition, country, sponsor and more.

Open in Search →

CC-122 Rollover Study Ended

2022-501855-97-00 Multiple Myeloma, Follicular Lymphoma, Diffuse Large B- 2023-06-29
Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants Ended

2023-504461-23-00 Fibrostenotic Crohn’s disease 2023-06-26
A Phase I, Single-Centre, Double-Blind, Randomized, Placebo-Controlled Clinical Trial To Determine Urinary Xylose Cut-Off Point For The Diag… Ended

2023-504232-18-00 Hypolactasia 2023-06-22
A study to test how well different doses of BI 1815368 are tolerated by healthy men Ended

2023-503815-13-00 Healthy 2023-06-19
Randomized, double-blind, placebo-controlled study assessing the safety, tolerability, pharmacokinetics and pharmacodynamics of pitolisant a… Ended

2023-503945-78-00 Narcolepsy with cataplexy 2023-06-13
A clinical trial in healthy people to look at how the body processes RO7268489 over time and when taken before or after a meal Ended

2023-503528-25-00 There is no medical condition being investigated. This 2023-06-09
A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Camizestrant in Post-menopausal … Ended

2022-502277-41-00 moderate or severe hepatic impairment 2023-06-05
Open label, Phase I study to assess and compare the pharmacokinetic parameters after multiple oral administration of stiripentol 1000 mg in … Ended

2024-516655-40-00 Patients with renal impairement 2023-06-02
A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who are Healthy Volunteers Co-administered the Medicine Ro… Ended

2023-503570-20-00 coronavirus disease 2019 (COVID-19) 2023-06-02
A randomized, double-blind, single-center, 2-period cross-over Phase I study to assess the tolerability, safety and pharmacokinetics of anti… Ended

2023-503971-45-00 Depression 2023-06-01
A Phase 1b, 2-part, placebo-controlled study to evaluate the efficacy, safety, and PK of PF-07054894 in participants with mild to severe UC. Ended

2022-501047-32-00 ULCERATIVE COLITIS 2023-05-30
A Double-Blind Placebo-Controlled Randomised Phase 1b Study of the Pharmacokinetics of ALE.F02 in Patients with Advanced Liver Fibrosis and/… Ended

2024-516455-40-00 Advanced liver fibrosis and/or mild liver cirrhosis 2023-05-25
A Phase 1, Multicentre, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single IV Dose of Rezafungin Acetat… Ended

2022-501985-23-00 Fungal infections 2023-05-18
Phase 1b study to evaluate MK 0482 for Relapsed/Refractory AML/CMML Ended

2023-503580-42-00 Active CNS leukemia. 2023-05-16
A Phase 2 Proof of Concept Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of OMS90… Ended

2022-501190-39-01 Paroxysmal nocturnal hemoglobinuria 2023-05-15
MK-7602 Multiple Ascending Dose Study in Healthy Participants Ended

2023-503738-36-00 Malaria 2023-05-12
Transcranial Magnetic Stimulation (TMS) Evaluation of Central Nervous System (CNS) Pharmacodynamic (PD) Activity of Brexanolone in Healthy M… Ended

2022-503019-40-00 NA, PD study in Healthy Volunteers 2023-05-11
Safety, tolerability and pharmacokinetics of intra‐articular (IA) single ascending dose of 4P‐004 in patient with Kellgren and Lawrence grad… Ended

2022-500271-31-00 Knee osteoarthritis 2023-05-10
A study to evaluate the effect of multiple doses of carbamazepine on how long aticaprant (JNJ-67953964) stays in the body (pharmacokinetics)… Ended

2022-502951-77-00 Healthy Adult Participants 2023-05-05
A study in healthy men to test how BI 764198 is processed in the body Ended

2022-502327-22-00 Healthy 2023-05-03
Pilot trial of single dose ilofotase alfa in hypophosphatasia Ended

2023-503186-35-00 Hypophosphatasia 2023-05-03
A Phase 1 Study Evaluating Relative Bioavailability of Sprinkled Ritlecitinib in Applesauce, Yoghurt, and Strawberry Jam and Evaluating the … Ended

2022-502872-22-00 Alopecia Areata, Rheumatoid Arthritis, Vitiligo, Ulcera 2023-04-28
Tramadol Administered Orally to Healthy Subjects for the Improvement of its Detection in Biological Matrices in the Context of Anti-Doping … Ended

2023-503799-25-00 healthy subjects 2023-04-27
A study in healthy men to test how BI 1291583 is processed in the body Ended

2022-502264-20-00 Healthy 2023-04-26